These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 37217907)
21. SARS-CoV-2 outbreaks on Danish mink farms and mitigating public health interventions. Dall Schmidt T; Mitze T Eur J Public Health; 2022 Feb; 32(1):151-157. PubMed ID: 34623404 [TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 Wave Two Surveillance in East Asia and the Pacific: Longitudinal Trend Analysis. Post LA; Lin JS; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh LN; White J; Boctor MJ; Welch SB; Oehmke JF J Med Internet Res; 2021 Feb; 23(2):e25454. PubMed ID: 33464207 [TBL] [Abstract][Full Text] [Related]
23. Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom's COVID-19 Public Health Response. Otter AD; Bown A; D'Arcangelo S; Bailey D; Semper A; Hewson J; Catton M; Perumal P; Sweed A; McKee DF; Jones J; Harvala H; Lamikanra A; Zambon M; Andrews N; Whitaker H; Linley E; Mentzer AJ; Skelly D; Knight JC; Klenerman P; ; Amirthalingam G; Taylor S; Rowe C; Vipond R; Brooks T Microbiol Spectr; 2022 Feb; 10(1):e0228921. PubMed ID: 35196807 [TBL] [Abstract][Full Text] [Related]
24. COVID-19 epidemic phases and morbidity in different areas of Chinese mainland, 2020. Wang Y; Yu J; Wang F; Zhang Y; Ma S Front Public Health; 2023; 11():1151038. PubMed ID: 37089485 [TBL] [Abstract][Full Text] [Related]
25. One health genomic surveillance and response to a university-based outbreak of the SARS-CoV-2 Delta AY.25 lineage, Arizona, 2021. Yaglom HD; Maurer M; Collins B; Hojnacki J; Monroy-Nieto J; Bowers JR; Packard S; Erickson DE; Barrand ZA; Simmons KM; Brock BN; Lim ES; Smith S; Hepp CM; Engelthaler DM PLoS One; 2022; 17(10):e0272830. PubMed ID: 36315517 [TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England. Ismail SA; Saliba V; Lopez Bernal J; Ramsay ME; Ladhani SN Lancet Infect Dis; 2021 Mar; 21(3):344-353. PubMed ID: 33306981 [TBL] [Abstract][Full Text] [Related]
27. An outbreak of SARS-CoV-2 in a public-facing office in England. Nicholls G; Atkinson B; van Veldhoven K; Nicholls I; Coldwell M; Clarke A; Atchison CJ; Raja AI; Bennett AM; Morgan D; Pearce N; Fletcher T; Brickley EB; Chen Y Occup Med (Lond); 2024 Oct; 74(7):475-485. PubMed ID: 38078549 [TBL] [Abstract][Full Text] [Related]
28. Developing a sentinel syndromic surveillance system using school-absenteeism data, example monitoring absences over the 2020 COVID-19 pandemic. Lai J; Hughes HE; Morbey R; Loveridge P; Lopez Bernal J; Saliba V; Kissling E; Lovelock-Wren A; Mabbitt J; Elliot AJ Epidemiol Infect; 2021 Nov; 149():e248. PubMed ID: 34749838 [TBL] [Abstract][Full Text] [Related]
29. Dynamic Panel Data Modeling and Surveillance of COVID-19 in Metropolitan Areas in the United States: Longitudinal Trend Analysis. Oehmke TB; Post LA; Moss CB; Issa TZ; Boctor MJ; Welch SB; Oehmke JF J Med Internet Res; 2021 Feb; 23(2):e26081. PubMed ID: 33481757 [TBL] [Abstract][Full Text] [Related]
30. A SARS-CoV-2 outbreak associated with five air force bases and a nightclub following the lifting of COVID-19-related social restrictions, United Kingdom, July-to-September 2021. Taylor MJ; Kumbang J; Bamford K; Mohammed Jazuli Ismail H; Huntley P; Liddle N; Errington J; Mair-Jenkins J Epidemiol Infect; 2023 Feb; 151():e26. PubMed ID: 36734116 [TBL] [Abstract][Full Text] [Related]
31. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
32. [Interrupting the chains of transmission of COVID-19 in Italy: survey among the Prevention Departments]. Salmaso S; Zambri F; Renzi M; Giusti A Epidemiol Prev; 2020; 44(5-6 Suppl 2):33-41. PubMed ID: 33412792 [TBL] [Abstract][Full Text] [Related]
33. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
34. Surveillance-based informative testing for detection and containment of SARS-CoV-2 outbreaks on a public university campus: an observational and modelling study. Rennert L; McMahan C; Kalbaugh CA; Yang Y; Lumsden B; Dean D; Pekarek L; Colenda CC Lancet Child Adolesc Health; 2021 Jun; 5(6):428-436. PubMed ID: 33751952 [TBL] [Abstract][Full Text] [Related]
35. A versatile web app for identifying the drivers of COVID-19 epidemics. Getz WM; Salter R; Luisa Vissat L; Horvitz N J Transl Med; 2021 Mar; 19(1):109. PubMed ID: 33726787 [TBL] [Abstract][Full Text] [Related]
36. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
37. Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England. de Lusignan S; Lopez Bernal J; Zambon M; Akinyemi O; Amirthalingam G; Andrews N; Borrow R; Byford R; Charlett A; Dabrera G; Ellis J; Elliot AJ; Feher M; Ferreira F; Krajenbrink E; Leach J; Linley E; Liyanage H; Okusi C; Ramsay M; Smith G; Sherlock J; Thomas N; Tripathy M; Williams J; Howsam G; Joy M; Hobbs R JMIR Public Health Surveill; 2020 Apr; 6(2):e18606. PubMed ID: 32240095 [TBL] [Abstract][Full Text] [Related]
38. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
39. COVID-19 Surveillance for Local Decision Making : An Academic, School District, and Public Health Collaboration. Hyder A; Trinh A; Padmanabhan P; Marschhausen J; Wu A; Evans A; Iyer R; Jones A Public Health Rep; 2021; 136(4):403-412. PubMed ID: 33979558 [TBL] [Abstract][Full Text] [Related]
40. Development and formative evaluation of the Canadian Armed Forces Surveillance and Outbreak Management System (CAF SOMS): applications for COVID-19 and beyond. Dubiniecki C; Gottschall S; Praught J Health Promot Chronic Dis Prev Can; 2022 Mar; 42(3):96-99. PubMed ID: 35262310 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]